Jason Luoma

Clinical Psychologist and Researcher

Data updated

Papers

11 publications

Trials

0 clinical trials

Links

Research Footprint

Jason Luoma appears in 11 tracked papers (2019–2026), most studied alongside MDMA, Psilocybin and Placebo, across Anxiety Disorders, Depressive Disorders and Palliative & End-of-Life Distress.

Most-cited paper: The use of the psychological flexibility model to support psychedelic assisted therapy (256 citations).

Frequent co-authors: Alan Davis, Christopher Stauffer and Gabrielle Agin-Liebes.

Background & Research

Jason B. Luoma is a clinical psychologist and researcher whose work sits at the intersection of contextual behavioural science and contemporary psychedelic research. His scholarship emphasises Acceptance and Commitment Therapy (ACT) and the psychological flexibility model as both theoretical foundations and practical supports for psychedelic-assisted interventions. Luoma has investigated how process-based psychotherapies can be adapted to the unique therapeutic context of psychedelic use and has published conceptual and empirical studies that translate ACT principles into preparatory, dosing, and integration phases of care.

Luoma's contributions include empirical research on attitudes and predictors of attitudes toward therapeutic psychedelic use among psychologists in the United States, prospective examinations of psychological flexibility and cognitive reappraisal in ceremonial ayahuasca contexts, and methodological and theoretical papers proposing a contextual psychedelic-assisted therapy approach. His work has helped clarify clinician readiness and training needs, highlighted the role of psychological processes (especially flexibility) in therapeutic outcomes, and advanced dialogue on how evidence-based behavioural therapies can be integrated with psychedelic-assisted treatment models.

Affiliations

Institutions, companies, and organisations Jason Luoma is associated with.